1981 studies found for:    "Bone Diseases"
Show Display Options
Rank Status Study
21 Completed Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis Patients
Conditions: Cystic Fibrosis;   Osteoporosis;   Bone Diseases, Metabolic
Interventions: Drug: Alendronate;   Drug: Placebo
22 Completed Short Term Bed Rest Study: Evaluation of the Use of Artificial Gravity, Induced by Short-arm Centrifugation
Conditions: Bone Diseases, Metabolic;   Acid-Base Imbalance;   Muscular Atrophy;   Sprains and Strains;   Protein Metabolism;   Body Weight Changes;   Cardiovascular Abnormalities
Intervention: Other: Defined Training Programme
23 Completed African-American Bone Metabolism and Lactation Study
Conditions: Lactation;   Bone Diseases, Endocrine
Intervention:
24 Not yet recruiting Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia
Conditions: Renal Insufficiency, Chronic;   Hyperphosphatemia;   Bone Diseases, Metabolic
Interventions: Drug: Lanthanum carbonate;   Drug: Calcium Carbonate
25 Active, not recruiting Patient Activation After DXA Result Notification
Conditions: Osteoporosis;   Bone Diseases, Metabolic
Intervention: Behavioral: Bone Mineral Density Result Letter and Bone Health Brochure
26 Completed Bone Metabolism and Parathyroid Hormone-related Protein (PTHrP) Lactation Study
Condition: Bone Diseases, Endocrine
Intervention:
27 Withdrawn One Week Comparison Study of PTH and PTHrP Infusions
Conditions: Osteoporosis;   Hypercalcemia of Malignancy;   Hyperparathyroidism;   Bone Diseases, Endocrine
Interventions: Drug: Parathyroid Hormone-related Protein (1-36);   Drug: parathyroid hormone (1-34);   Drug: PTH (1-34) and PTHrP (1-36)
28 Completed Effects of Naturally Silicon-Rich Water on Bone Metabolism in Women
Condition: Bone Diseases, Metabolic
Intervention: Other: Fiji Water
29 Completed 7 Day Continuous Parathyroid Hormone IV Infusion
Conditions: Osteoporosis;   Bone Diseases, Endocrine;   Hyperparathyroidism
Intervention: Drug: parathyroid hormone (1-34)
30 Completed Use of Bone Biopsy to Better Understand the Causes of Decreased Bone Mineral Density in Depression
Conditions: Bone Diseases, Metabolic;   Depression, Involutional;   Osteoporosis
Intervention:
31 Recruiting Bisphosphonate Users Radiographic Characteristics of the Hip (BURCH) Study
Conditions: Osteoporosis;   Bone Diseases, Metabolic;   Hip Fractures
Intervention:
32 Recruiting Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors
Conditions: Hypopituitarism;   Hypogonadism;   Thyroid Dysfunction;   Bone Diseases, Metabolic
Intervention:
33 Completed Dried Plums for Bone Health in Older Postmenopausal Women
Condition: Bone Diseases, Metabolic
Intervention: Other: Dried Plum
34 Unknown  The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 ( FGF23) in Chronic Kidney Disease
Condition: Metabolic Bone Disease
Interventions: Drug: Lanthanum Carbonate;   Drug: Fosrenol;   Drug: placebo
35 Suspended Calciuric Effect and Cyclic Parenteral Nutrition in Preterm Infants
Conditions: Preterm Infants;   Metabolic Bone Disease
Intervention:
36 Completed Study of Skeletal Disorders and Short Stature
Conditions: Developmental Bone Disease;   Dwarfism;   Skeletal Dysplasias
Intervention:
37 Completed
Has Results
Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease
Conditions: Breast Cancer;   Prostate Cancer;   Bone Neoplasms
Interventions: Drug: AZD0530;   Drug: Zoledronic Acid
38 Recruiting XL184 For Relapsed/Refractory Multiple Myeloma (MM) With Bone Disease
Condition: Multiple Myeloma
Intervention: Drug: Cabozantinib
39 Recruiting Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Conditions: Cancer;   Hematologic Malignancies;   Multiple Myeloma;   Oncology;   Bone Metastases;   Multiple Myeloma Bone Lesions
Interventions: Drug: Denosumab;   Drug: Zoledronic acid
40 Completed A Study to Evaluate Food Effect on ONO-5920/YM529 Intermittent Formulation
Conditions: Osteoporosis;   Osteoporosis, Postmenopausal;   Bone Diseases
Intervention: Drug: ONO-5920 / YM529

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years